Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Nov 15, 2021

BUY
$59.21 - $78.66 $1.3 Million - $1.73 Million
22,000 Added 24.44%
112,000 $7.29 Million
Q2 2021

Aug 16, 2021

BUY
$51.39 - $66.9 $4.63 Million - $6.02 Million
90,000 New
90,000 $5.71 Million
Q4 2020

Feb 16, 2021

SELL
$42.19 - $51.5 $1.27 Million - $1.55 Million
-30,000 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$35.33 - $51.04 $1.06 Million - $1.53 Million
30,000 New
30,000 $1.53 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.